Sumitomo Mitsui Trust Holdings Inc. Has $22.52 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Sumitomo Mitsui Trust Holdings Inc. decreased its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 4.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 521,677 shares of the company’s stock after selling 23,190 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 0.23% of Bath & Body Works worth $22,516,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Denali Advisors LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at about $27,000. Money Concepts Capital Corp increased its stake in shares of Bath & Body Works by 1,180.4% in the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company’s stock valued at $28,000 after buying an additional 602 shares during the period. Front Row Advisors LLC acquired a new stake in shares of Bath & Body Works in the third quarter valued at about $25,000. Trust Co. of Vermont acquired a new stake in shares of Bath & Body Works in the third quarter valued at about $27,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at about $35,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $43.99 on Monday. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.34. The business’s 50 day simple moving average is $46.15 and its two-hundred day simple moving average is $40.19. The firm has a market cap of $9.89 billion, a P/E ratio of 11.43, a PEG ratio of 1.43 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same quarter last year, the company earned $1.86 earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.82%. Bath & Body Works’s dividend payout ratio is presently 20.78%.

Analyst Ratings Changes

Several brokerages recently commented on BBWI. TD Cowen upped their target price on Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Piper Sandler upped their target price on Bath & Body Works from $44.00 to $45.00 and gave the company a “neutral” rating in a research report on Tuesday, April 9th. BMO Capital Markets upped their target price on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Barclays lowered Bath & Body Works from an “overweight” rating to an “equal weight” rating and upped their target price for the company from $37.00 to $45.00 in a research report on Thursday, January 4th. Finally, The Goldman Sachs Group upped their target price on Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and a consensus price target of $46.33.

Insider Activity

In other news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now owns 45,992 shares in the company, valued at $2,248,548.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company’s stock.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.